Ghost Tree Capital’s Juno Therapeutics, Inc. JUNO Stock Holding History

Ghost Tree Capital’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-150,000	Closed	-$6.86M	–	77
2017 Q4	$6.86M	Buy	150,000 +50,000	+50%	+$2.49M	1.61%	23
2017 Q3	$4.49M	Sell	100,000 -175,000	-64%	-$5.97M	0.95%	38
2017 Q2	$8.22M	Buy	+275,000	New	+$6.79M	1.71%	18

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Ghost Tree Capital's JUNO Position: Q1 2018 in Review

Ghost Tree Capital sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 150,000 shares — an estimated $6.86M sold.

Ghost Tree Capital first reported a position in JUNO in Q2 2017 and held it in 3 quarters. The position peaked at $8.22M in Q2 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Ghost Tree Capital reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Ghost Tree Capital sold 150,000 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $6.86M.
Ghost Tree Capital first reported a position in Juno Therapeutics, Inc. in Q2 2017 and held it in 3 quarters.
Ghost Tree Capital's Juno Therapeutics, Inc. position peaked at $8.22M in Q2 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Ghost Tree Capital's 13F filing for Q1 2018, filed 15 May 2018.